the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Couple charged with neglecting baby changes plea

CHUKAI: A couple who had pleaded guilty to neglecting their seven-day-old baby boy changed their plea in the Sessions Court here today.

Nur Aisyah Azila Zairul Akmal, 21, and Muhammad Alhafiz Mukminin Mohd Noor, 24, changed their pleas to not guilty and claim trial to the charge before Judge Wan Suhaila Mohd.

Wan Suhaila set July 31 for mention for the submission of documents and the results of the deoxyribonucleic acid (DNA) test.

Deputy public prosecutor Syairah Mohamad Razali appeared for the prosecution, while the two accused were represented by lawyer Nurul Farhana Shamsudin from the National Legal Aid Foundation (YBGK).

Last Thursday, the couple pleaded guilty to the charge.

ALSO READ: Young couple plead guilty to neglecting newborn baby

They were jointly charged as persons having custody of the baby, to have neglected in a manner likely to cause physical injury to the infant.

The offence was allegedly committed at a shop in Jalan Air Putih here, between 7am and 7.15am, on May 18.

The charge was framed under Section 31(1) (a) of the Child Act 2001 and can be punished under Section 31(1) of the same law, and, read together with Section 34 of the Penal Code, which provides for a maximum fine of RM50,000 or imprisonment not exceeding 20 years, or both, upon conviction.

The court allowed them bail of RM2,000 in one surety each and set today (May 28) for sentencing.

ALSO READ: Baby girl dies after being left inside car at hospital parking lot

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings